RG7356 New Monoclonal Antibody: 'The molecule... - CLL Support

CLL Support

23,089 members39,652 posts

RG7356 New Monoclonal Antibody

Cllcanada profile image
CllcanadaTop Poster CURE Hero
0 Replies

'The molecule, called a monoclonal antibody, is being readied for human clinical trials for CLL "in the not-too-distant future," said lead researcher Thomas J. Kipps in a statement on the results.

Kipps holds the Evelyn and Edwin Tasch Chair in Cancer Research ath the UCSD Moores Cancer Center.'

'Named RG7356, the "humanized" monoclonal antibody targets a receptor or surface molecule, called CD44, found on the CLL cells. The antibody is toxic to the cells, according to laboratory studies.'

Article

utsandiego.com/news/2013/ma...

FULL PAPER

pnas.org/content/early/2013...

Written by
Cllcanada profile image
Cllcanada
Top Poster CURE Hero
To view profiles and participate in discussions please or .
Read more about...

Not what you're looking for?

You may also like...

Access to Monoclonal Antibody Treatment in Mexico

I have CLL and in W&W. Age 65, otherwise healthy. No antibodies after first 2 Pfizers, positive for...

Development of AstraZeneca's SARS-CoV2 spike monoclonal antibodies (AZD7442)

Thank you bennevisplace for posting about AstraZeneca's monoclonal antibody clinical trial for...

Promising clinical results for new drug combination for CLL (GA101 plus Chlorambucil)

Some information from Cardiff to add to the recent GA101 posts...

MONOCLONAL ANTIBODY INFUSIONS TOO SOON?

After I was exposed recently to a two year old who had symptoms and tested positive for COVID, I...

New "kid" on the therapy block

No direct experience with ADCT-402 but never short on being curious and sharing uncredentialed...